NorthWest Biotherapeutics Inc (NWBO)

[tryn2]

Sojo wrote:”BMY and Gilead both have around $80B market cap. BMY bought Celgene which in turn bought JUNO for $9B whereas Gilead bought KITE for $11B. Merck is the $200B gorilla that has yet to follow with a major acquisition and I think they are hungry for one, IMO.”

This is EXACTLY what I am talking about...:)
Merck lends out their executive to guide their newly acquired property to fda approval....
The deal is not required to be PR’d yet because the terms are not yet set...